Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 7, 2012, Pages 712-721.e4

  Lovell, Rebecca M ^a   Ford, Alexander C ^a,b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Abdominal pain; Bloating; Incidence; Rate

Indexed keywords

HIGH RISK POPULATION; HUMAN; IRRITABLE COLON; META ANALYSIS; PREVALENCE; QUESTIONNAIRE; REVIEW; RISK FACTOR; SEX DIFFERENCE;

EID: 84862651150     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.02.029     Document Type: Review

References (115)

1. Longstreth G.F., Thompson W.G., Chey W.D., et al. Functional bowel disorders. Gastroenterology 2006, 130:1480-1491.
2. Agréus L., Svärdsudd K., Nyrén O., et al. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995, 109:671-680.
3. Ford A.C., Forman D., Bailey A.G., et al. Irritable bowel syndrome: a 10-year natural history of symptoms, and factors that influence consultation behavior. Am J Gastroenterol 2008, 103:1229-1239.
4. Halder S.L., Locke G.R., Schleck C.D., et al. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology 2007, 133:799-807.
5. Koloski N.A., Talley N.J., Boyce P.M. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol 2002, 97:2290-2299.
6. Koloski N.A., Talley N.J., Huskic S.S., et al. Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2003, 17:841-851.
7. May C., Allison G., Chapple A., et al. Framing the doctor-patient relationship in chronic illness: a comparative study of general practitioners' accounts. Sociol Health Illn 2004, 26:135-158.
8. Sandler R.S., Everhart J.E., Donowitz M., et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002, 122:1500-1511.
9. Maxion-Bergemann S., Thielecke F., Abel F., et al. Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics 2006, 24:21-37.
10. Moriarty K.J., Dawson A.M. Functional abdominal pain: further evidence that whole gut is affected. Br Med J 1982, 284:1670-1672.
11. Trimble K.C., Farouk R., Pryde A., et al. Heightened visceral sensation in functional gastrointestinal disease is not site-specific: evidence for a generalized disorder of gut sensitivity. Dig Dis Sci 1995, 40:1607-1613.
12. Stanghellini V., Tosetti C., Barbara G., et al. Dyspeptic symptoms and gastric emptying in the irritable bowel syndrome. Am J Gastroenterol 2002, 97:2738-2743.
13. Cann P.A., Read N.W., Brown C., et al. Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns. Gut 1983, 24:405-411.
14. Kassinen A., Krogius-Kurikka L., Mäkivuokko H., et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007, 133:24-33.
15. Mearin F., Perelló A., Balboa A., et al. Pathogenic mechanisms of postinfectious functional gastrointestinal disorders: results 3 years after gastroenteritis. Scand J Gastroenterol 2009, 44:1173-1185.
16. Wang L.H., Fang X.C., Pan G.Z. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 2004, 53:1096-1101.
17. Weston A.P., Biddle W.L., Bhatia P.S., et al. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993, 38:1590-1595.
18. Tillisch K., Mayer E.A., Labus J.S. Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome. Gastroenterology 2011, 140:91-100.
19. Drossman D.A., Whitehead W.E., Toner B.B., et al. What determines severity amongst patients with painful functional bowel disorders?. Am J Gastroenterol 2000, 95:974-980.
20. Drossman D.A., Li Z., Andruzzi E., et al. U.S. householder survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact. Dig Dis Sci 1993, 38:1569-1580.
21. Jones R., Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992, 304:87-90.
22. Kennedy T.M., Jones R.H., Hungin A.P., et al. Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut 1998, 43:770-774.
23. Talley N.J., Zinsmeister A.R., Van Dyke C., et al. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991, 101:927-934.
24. Manning A.P., Thompson W.G., Heaton K.W., et al. Towards positive diagnosis of the irritable bowel. Br Med J 1978, 277:653-654.
25. Drossman D.A., Thompson W.G., Talley N.J. Identification of sub-groups of functional gastrointestinal disorders. Gastroenterol Int 1990, 3:159-172.
26. Thompson W.G., Longstreth G.F., Drossman D.A., et al. Functional bowel disorders and functional abdominal pain. Gut 1999, 45(Suppl II):II43-II47.
27. Higgins J.P., Thompson S.G., Deeks J.J., et al. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
28. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
29. Egger M., Davey-Smith G., Schneider M., et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
30. Sterne J.A., Sutton A.J., Ioannidis J.P., et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011, 343:d4002.
31. Aggarwal V.R., McBeth J., Zakrzewska J.M., et al. The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors?. Int J Epidemiol 2006, 35:468-476.
32. Agréus L., Talley N.J., Svärdsudd K., et al. Identifying dyspepsia and irritable bowel syndrome: the value of pain or discomfort, and bowel habit descriptors. Scand J Gastroenterol 2000, 35:142-151.
33. Amra B., Hoseini-Asl M.K., Rahmani A.R., et al. Correlation between asthma and irritable bowel syndrome in a general population in Iran in 2003. Respir Med 2006, 100:110-114.
34. Andrews E.B., Eaton S.C., Hollis K.A., et al. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Aliment Pharmacol Ther 2005, 22:935-942.
35. Aro P., Ronkainen J., Storskrubb T., et al. Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol 2004, 39:1280-1288.
36. Baretic M., Bilic A., Jurcic D., et al. Epidemiology of irritable bowel syndrome in Croatia. Coll Antropol 2002, 26(Suppl):85-91.
37. Basaranoglu M., Celebi S., Ataseven H., et al. Prevalence and consultation behavior of self-reported rectal bleeding by face-to-face interview in an Asian community. Digestion 2008, 77:10-15.
38. Boekema P.J., van Dam van Isselt E.F., Bots M.L., et al. Functional bowel symptoms in a general Dutch population and associations with a common stimulus. Neth J Med 2001, 59:23-30.
39. Bommelaer G., Dorval E., Denis P., et al. Prevalence of irritable bowel syndrome in the French population according to the Rome I criteria. Gastroenterol Clin Biol 2002, 26:1118-1123.
40. Bommelaer G., Poynard T., Le Pen C., et al. Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria. Gastroenterol Clin Biol 2004, 28:554-561.
41. Boyce P.M., Koloski N.A., Talley N.J. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?. Am J Gastroenterol 2000, 95:3176-3183.
42. Caballero-Plasencia A.M., Sofos-Kontoyannis S., Valenzuela-Barranco M., et al. Irritable bowel syndrome in patients with dyspepsia: a community-based study in Southern Europe. Eur J Gastroenterol Hepatol 1999, 11:517-522.
43. Campos Hurtado G., León Barúa R., Villareal Menchola J., et al. [Association between irritable intestinal syndrome and depressive symptoms in a population of high socioeconomic level of Lima]. Rev Gastroenterol Peru 2001, 21:198-204.
44. Celebi S., Acik Y., Deveci S.E., et al. Epidemiological features of irritable bowel syndrome in a Turkish urban society. J Gastroenterol Hepatol 2004, 19:738-743.
45. Chen L.Y., Ho K.Y., Phua K.H. Normal bowel habits and prevalence of functional bowel disorders in Singaporean adults: findings from a community based study in Bishan. Singapore Med J 2000, 41:255-258.
46. Cheung T.K., Lam K.F., Hu W.H., et al. Positive association between gastro-oesophageal reflux disease and irritable bowel syndrome in a Chinese population. Aliment Pharmacol Ther 2007, 25:1099-1104.
47. Choo K.Y., Choi M.G., Choi H., et al. [The prevalence of gastrointestinal symptoms in a rural community in Korea]. Korean J Gastrointest Motil 2000, 6:31-43.
48. Corazziari E., Attili A.F., Angeletti C., et al. Gallstones, cholecystectomy and irritable bowel syndrome (IBS): MICOL population-based study. Dig Liver Dis 2008, 40:944-950.
49. Curioso W.H., Mendoza N.D., Zerpa C.B., et al. [Prevalence and relation of dyspepsia to irritable bowel syndrome in a native community of the Peruvian jungle]. Rev Gastroenterol Peru 2002, 22:129-140.
50. Danivat M., Tankeyoon M., Sriratanaban A. Prevalence of irritable bowel syndrome in a non-Western population. BMJ 1988, 296:1710.
51. Dapoigny M., Bellanger J., Bonaz B., et al. Irritable bowel syndrome in France: a common, debilitating and costly disorder. Eur J Gastroenterol Hepatol 2004, 16:995-1001.
52. Drug V.L., Oprea L., Bunescu D., et al. The epidemiology of irritable bowel syndrome in an urban general population. Rom J Gastroenterol 2000, 9:83-86.
53. Ebling B., Jurcić D., Gmajnić R., et al. Anthropological, demographic, and socioeconomic characteristics of irritable bowel syndrome. Coll Antropol 2011, 35:513-521.
54. Gómez Alvarez D.F., Morales Vargas J.G., Rojas Medina L.M., et al. [Prevalence of irritable bowel syndrome and associated factors according to the Rome III diagnostic criteria in a general population in Colombia]. Gastroenterol Hepatol 2009, 32:395-400.
55. Gwee K.A., Wee S., Wong M.L., et al. The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an Asian urban community. Am J Gastroenterol 2004, 99:924-931.
56. Han S.H., Lee O.Y., Bae S.C., et al. Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria. J Gastroenterol Hepatol 2006, 21:1687-1692.
57. Heaton K.W., O'Donnell L.J., Braddon F.E., et al. Symptoms of irritable bowel syndrome in a British urban community: consulters and non-consulters. Gastroenterology 1992, 102:1962-1967.
58. Herschbach P., Henrich G., von Rad M. Psychological factors in functional gastrointestinal disorders: characteristics of the disorder or the illness behavior?. Psychosom Med 1999, 61:148-153.
59. Hillilä M.T., Färkkilä M.A. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population. Aliment Pharmacol Ther 2004, 20:339-345.
60. Ho K.Y., Kang J.Y., Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol 1998, 93:1816-1822.
61. Holtmann G., Goebell H., Talley N.J. Dyspepsia in consulters and non-consulters: prevalence, health-care seeking behaviour and risk factors. Eur J Gastroenterol Hepatol 1994, 6:917-924.
62. Hongo M. Epidemiology of FGID symptoms in Japanese general population with reference to life style. J Gastroenterol Hepatol 2011, 26(Suppl 3):19-22.
63. Husain N., Chaudhry I.B., Jafri F., et al. A population-based study of irritable bowel syndrome in a non-Western population. Neurogastroenterol Motil 2008, 20:1022-1029.
64. Icks A., Haastert B., Enck P., et al. Prevalence of functional bowel disorders and related health care seeking: a population-based study. Z Gastroenterol 2002, 40:177-183.
65. Jafri W., Yakoob J., Jafri N., et al. Irritable bowel syndrome and health seeking behaviour in different communities of Pakistan. J Pak Med Assoc 2007, 57:285-287.
66. Jeong J.J., Choi M.G., Cho Y.S., et al. Chronic gastrointestinal symptoms and quality of life in the Korean population. World J Gastroenterol 2008, 14:6388-6394.
67. Karaman N., Türkay C., Yönem O. Irritable bowel syndrome prevalence in city center of Sivas. Turk J Gastroenterol 2003, 14:128-131.
68. Khademolhosseini F., Mehrabani D., Nejabat M., et al. Irritable bowel syndrome in adults over 35 years in Shiraz, southern Iran: prevalence and associated factors. J Res Med Sci 2011, 16:200-206.
69. Khoshkrood-Mansoori B., Pourhoseingholi M.A., Safaee A., et al. Irritable bowel syndrome: a population based study. J Gastrointest Liver Dis 2009, 18:413-418.
70. Kumano H., Kaiya H., Yoshiuchi K., et al. Comorbidity of irritable bowel syndrome, panic disorder, and agoraphobia in a Japanese representative sample. Am J Gastroenterol 2004, 99:370-376.
71. Kwan A.C., Hu W.H., Chan Y.K., et al. Prevalence of irritable bowel syndrome in Hong Kong. J Gastroenterol Hepatol 2002, 17:1180-1186.
72. Lau E.M., Chan F.K., Ziea E.T., et al. Epidemiology of irritable bowel syndrome in Chinese. Dig Dis Sci 2002, 47:2621-2624.
73. Lee S., Wu J., Ma Y.L., et al. Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study. Aliment Pharmacol Ther 2009, 30:643-651.
74. Lee S.Y., Lee K.J., Kim S.J., et al. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study. Digestion 2009, 79:196-201.
75. Li F.X., Patten S.B., Hilsden R.J., et al. Irritable bowel syndrome and health-related quality of life: a population-based study in Calgary, Alberta. Can J Gastroenterol 2003, 17:259-263.
76. Talley N.J., Boyce P.M., Jones M. Is the association between irritable bowel syndrome and abuse explained by neuroticism?. A population based study. Gut 1998, 42:47-53.
77. Lydiard R.B., Greenwald S., Weissman M.M., et al. Panic disorder and gastrointestinal symptoms: findings from the NIMH epidemiologic catchment area project. Am J Psychiatry 1994, 151:64-70.
78. Masud M.A., Hasan M., Khan A.K. Irritable bowel syndrome in a rural community in Bangladesh: prevalence, symptom pattern, and health care seeking behavior. Am J Gastroenterol 2001, 96:1547-1552.
79. Mearin F., Badía X., Balboa A., et al. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001, 36:1155-1161.
80. Nicholl B.I., Halder S.L., MacFarlane G.J., et al. Psychosocial risk markers for new onset irritable bowel syndrome: results of a large prospective population-based study. Pain 2008, 137:147-155.
81. Okeke E.N., Ladep N.G., Adah S., et al. Prevalence of irritable bowel syndrome: a community survey in an African population. Ann Afr Med 2009, 8:177-180.
82. Olafsdóttir L.B., Gudjónsson H., Thjódleifsson B. [Epidemiological study of functional bowel disorders in Iceland]. Laeknabladid 2005, 91:329-333.
83. Osterberg E., Blomquist L., Krakau I., et al. A population study on irritable bowel syndrome and mental health. Scand J Gastroenterol 2000, 35:264-268.
84. Pan G., Lu S., Ke M., et al. Epidemiologic study of the irritable bowel syndrome in Beijing: stratified randomized study by cluster sampling. Chin Med J (Engl) 2000, 113:35-39.
85. Papatheoridis G.V., Karamanolis D.G. Prevalence and impact of upper and lower gastrointestinal symptoms in the Greek urban general population. Scand J Gastroenterol 2005, 40:412-421.
86. Perveen I., Hasan M., Masud M.A., et al. Irritable bowel syndrome in a Bangladeshi urban community: prevalence and health care seeking pattern. Saudi J Gastroenterol 2009, 15:239-243.
87. Rajendra S., Alahuddin S. Prevalence of irritable bowel syndrome in a multi-ethnic Asian population. Aliment Pharmacol Ther 2004, 19:707-708.
88. Reshetnikov O.V., Kurilovich S.A., Bobak M., et al. [Gastrointestinal symptoms in adult population of Novosibirsk city: prevalence and risk factors]. Ter Arkh 2009, 81:11-16.
89. Saito Y.A., Locke G.R., Talley N.J., et al. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol 2000, 95:2816-2824.
90. Segal I. The irritable bowel syndrome in the black community. S Afr Med J 1984, 65:73-74.
91. Soares R.L., dos Santos J.M., Rocha V.R. Prevalence of irritable bowel syndrome in a Brazilian Amazon community. Neurogastroenterol Motil 2005, 17:883.
92. Sperber A.D., Shvartzman P., Friger M., et al. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the "true" prevalence of irritable bowel syndrome?. Eur J Gastroenterol Hepatol 2007, 19:441-447.
93. Talley N.J., Weaver A.L., Zinsmeister A.R., et al. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992, 136:165-177.
94. Talley N.J., Fett S.L., Zinsmeister A.R., et al. Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology 1994, 107:1040-1049.
95. Talley N.J., Zinsmeister A.R., Melton L.J. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 1995, 142:76-83.
96. Talley N.J., Boyce P.M., Owen B.K., et al. Initial validation of a bowel symptom questionnaire and measurement of chronic gastrointestinal symptoms in Australians. Aust N Z J Med 1995, 25:302-308.
97. Talley N.J., Boyce P.M., Jones M. Predictors of health care seeking for irritable bowel syndrome: a population based study. Gut 1997, 41:394-398.
98. Thompson W.G., Irvine E.J., Pare P., et al. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002, 47:225-235.
99. Usai P., Manca R., Lai M.A., et al. Prevalence of irritable bowel syndrome in Italian rural and urban areas. Eur J Intern Med 2010, 21:324-326.
100. Walter S.A., Kjellström L., Nyhlin H., et al. Assessment of normal bowel habits in the general adult population: the Popcol study. Scand J Gastroenterol 2010, 45:556-566.
101. Wei X., Chen M., Wang J. [The epidemiology of irritable bowel syndrome and functional constipation of Guangzhou residents]. Chin J Intern Med 2001, 40:517-520.
102. Whitehead W.E., Winget C., Fedoravicius A.S., et al. Learned illness behavior in patients with irritable bowel syndrome and peptic ulcer. Dig Dis Sci 1982, 27:202-208.
103. Wilson S., Roberts L., Roalfe A., et al. Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract 2004, 54:495-502.
104. Xiong L.S., Chen M.H., Chen H.X., et al. A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling. Aliment Pharmacol Ther 2004, 19:1217-1224.
105. Yilmaz S., Dursun M., Ertem M., et al. The epidemiological aspects of irritable bowel syndrome in southeastern Anatolia: a stratified randomised community-based study. Int J Clin Pract 2005, 59:361-369.
106. Zagari R.M., Law G.R., Fuccio L., et al. Epidemiology of functional dyspepsia and subgroups in the Italian general population: an endoscopic study. Gastroenterology 2010, 138:1302-1311.
107. Zhao Y., Zou D., Wang R., et al. Dyspepsia and irritable bowel syndrome in China: a population-based endoscopy study of prevalence and impact. Aliment Pharmacol Ther 2010, 32:562-572.
108. Kang J.Y. Systematic review: the influence of geography and ethnicity in irritable bowel syndrome. Aliment Pharmacol Ther 2005, 21:663-676.
109. Saito Y.A., Schoenfeld P., Locke G.R. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002, 97:1910-1915.
110. Guilera M., Balboa A., Mearin F. Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review. Am J Gastroenterol 2005, 100:1174-1184.
111. Inadomi J.M., Fennerty M.B., Bjorkman D. Systematic review: the economic impact of irritable bowel syndrome. Aliment Pharmacol Ther 2003, 18:671-682.
112. Ford A.C., Talley N.J., Spiegel B.M.R., et al. Effect of fibre, antispasmodics, and peppermint oil in irritable bowel syndrome: systematic review and meta-analysis. BMJ 2008, 337:1388-1392.
113. 4 agonists in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol 2009, 104:1831-1843.
114. Ford A.C., Talley N.J., Schoenfeld P.S., et al. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 2009, 58:367-378.
115. Moayyedi P., Ford A.C., Brandt L.J., et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: A systematic review. Gut 2010, 59:325-332.